Advertisement

---

ECHO THERAPEUTICS, INC.

Echo Therapeutics Provides Mid-Year Update to Shareholders

[2013-07-03] - Company Streamlines Cost Structure with Focus on Achieving Critical Milestones


Echo Therapeutics Regains Compliance with Nasdaq Listing Requirements

[2013-06-26] -


Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter

[2013-06-19] -


Echo Therapeutics Announces Pricing of Public Offering of Common Stock

[2013-06-13] -


Echo Therapeutics Submits Pre-Submission Package to FDA for Symphony® CGM System

[2013-06-10] -


Echo Therapeutics Announces Reverse Split of Common Stock

[2013-06-06] - Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on June 7, 2013


Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony® CGM System

[2013-06-05] -


Echo Therapeutics to Present at the Jefferies Global Healthcare Conference

[2013-05-30] -


Notified Body Accepts Echo Therapeutics' Clinical Trial Plan for Symphony® CGM System

[2013-05-29] - Data from the trial will support CE Marking


Echo Therapeutics Announces Successful Unveiling of Symphony® CGM System

[2013-05-23] - Demonstration Followed Stockholders Approval of All Resolutions at Annual Meeting


Echo Therapeutics Announces Institutional Review Board (IRB) Approval for Its Clinical Trial of the Symphony® CGM System

[2013-05-21] -


Echo Therapeutics Announces First Quarter 2013 Financial Results

[2013-05-10] -


1 - 2
Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers